Current concepts and new developments for autologous in vivo endothelialisation of biomaterials for intravascular applications.

Eur Cell Mater

Clinical Research Laboratory, Department of Congenital and Paediatric Cardiac Surgery, University Children´s Hospital Tuebingen, Calwerstrasse 7/1, Tuebingen, Germany.

Published: February 2011

Circulating endothelial progenitor cells (EPCs) in the peripheral blood of adults represent an auspicious cell source for tissue engineering of an autologous endothelium on blood-contacting implants. Novel materials biofunctionalised with EPC-specific capture molecules represent an intriguing strategy for induction of selective homing of progenitor cells. The trapped EPCs can differentiate into endothelial cells and generate a non-thrombogenic surface on artificial materials. However, the success of this process mainly depends on the use of optimised capture molecules with a high selectivity and affinity. In recent years, various biomedical engineering strategies have emerged for in situ immobilisation of patient's own stem cells on blood contacting materials. The realisation of this in vivo tissue engineering concept and generation of an endothelium on artificial surfaces could exceedingly enhance the performance of not only small calibre vascular grafts and stents, but also, in general all blood-contacting medical devices, such as heart valves, artificial lungs, hearts, kidneys, and ventricular assist devices.

Download full-text PDF

Source
http://dx.doi.org/10.22203/ecm.v021a13DOI Listing

Publication Analysis

Top Keywords

progenitor cells
8
tissue engineering
8
capture molecules
8
current concepts
4
concepts developments
4
developments autologous
4
autologous vivo
4
vivo endothelialisation
4
endothelialisation biomaterials
4
biomaterials intravascular
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!